华厦眼科
(301267)
| 流通市值：93.18亿 | | | 总市值：120.71亿 |
| 流通股本：6.48亿 | | | 总股本：8.40亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 2,185,227,265.04 | 1,150,088,313.1 | 4,139,163,024.64 | 3,271,797,099.4 |
| 营业总成本 | 1,819,478,008.53 | 926,648,751.89 | 3,566,671,659.42 | 2,700,081,162.64 |
| 其他经营收益 | | | | |
| 营业利润 | 399,193,137.74 | 242,239,327.45 | 615,595,126.37 | 614,861,999.21 |
| 利润总额 | 391,106,231.44 | 235,469,409.51 | 573,812,327.59 | 579,988,215.19 |
| 净利润 | 303,441,152.35 | 184,252,848.42 | 433,056,268.76 | 456,066,099.99 |
| 每股收益 | | | | |
| 其他综合收益 | -502,240.63 | -266,313.61 | -1,029,332.98 | -624,557.42 |
| 综合收益总额 | 302,938,911.72 | 183,986,534.81 | 432,026,935.78 | 455,441,542.57 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 4,683,927,464.62 | 4,585,639,515.2 | 4,371,205,323.26 | 4,917,624,038.8 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,101,936,657.51 | 3,129,231,420.93 | 3,184,748,967.71 | 3,245,506,762.22 |
| 资产总计 | 7,785,864,122.13 | 7,714,870,936.13 | 7,555,954,290.97 | 8,163,130,801.02 |
| 流动负债: | | | | |
| 流动负债合计 | 1,323,048,224.41 | 1,199,672,005.61 | 1,137,352,567.16 | 1,092,328,897.28 |
| 非流动负债: | | | | |
| 非流动负债合计 | 862,193,196.14 | 888,538,762.11 | 965,750,383.74 | 862,456,864.68 |
| 负债合计 | 2,185,241,420.55 | 2,088,210,767.72 | 2,103,102,950.9 | 1,954,785,761.96 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 5,420,497,616.3 | 5,441,971,454.79 | 5,270,575,487.46 | 5,998,641,817.34 |
| 股东权益合计 | 5,600,622,701.58 | 5,626,660,168.41 | 5,452,851,340.07 | 6,208,345,039.06 |
| 负债和股东权益合计 | 7,785,864,122.13 | 7,714,870,936.13 | 7,555,954,290.97 | 8,163,130,801.02 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,262,078,090.23 | 1,170,255,253.2 | 4,256,819,713.41 | 3,331,087,546.3 |
| 经营活动现金流出小计 | 1,781,418,387.32 | 869,972,736.82 | 3,389,237,428.57 | 2,632,976,856.62 |
| 经营活动产生的现金流量净额 | 480,659,702.91 | 300,282,516.38 | 867,582,284.84 | 698,110,689.68 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 2,208,530,723.78 | 718,532,836.4 | 11,845,280,947.77 | 6,460,499,929.45 |
| 投资活动现金流出小计 | 4,140,514,878.75 | 2,634,114,220.45 | 12,921,514,529.66 | 9,327,290,666.34 |
| 投资活动产生的现金流量净额 | -1,931,984,154.97 | -1,915,581,384.05 | -1,076,233,581.89 | -2,866,790,736.89 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 30,000,000 | 0 | 60,567,000 | 30,190,000 |
| 筹资活动现金流出小计 | 147,892,579.02 | 87,213,339.96 | 828,714,800.82 | 421,524,969.96 |
| 筹资活动产生的现金流量净额 | -117,892,579.02 | -87,213,339.96 | -768,147,800.82 | -391,334,969.96 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -1,569,217,031.08 | -1,702,512,207.63 | -976,799,097.87 | -2,560,015,017.17 |
| 期末现金及现金等价物余额 | 923,525,184.51 | 790,230,007.96 | 2,492,742,215.59 | 909,526,296.29 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -1,569,217,031.08 | - | -976,799,097.87 | - |
最新报告期：2026-09-30| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中信建投 | 刘慧彬,王在存,贺菊颖 | 0.60 | 0.67 | 0.73 | 2026-09-30 |
| 东海证券 | 杜永宏 | 0.62 | 0.69 | 0.78 | 2026-09-14 |
| 华泰证券 | 代雯,高鹏 | 0.60 | 0.68 | 0.78 | 2026-08-27 |